Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research

Concerns are being raised about the potential undermining of medical research due to the emergence of prediction markets that allow people to bet on drug approvals. Kalshi and Polymarket are two platforms that currently offer such markets, enabling individuals to wager money on the outcome of drug approvals. Kalshi is also planning to expand its offerings to include betting on clinical trial results, further fueling concerns about the impact on research integrity. This development has sparked worries about the potential for betting to influence or compromise the drug development process.

✦ AI-generated summary